HR+/HER2- Advanced Breast Cancer and Endocrine Resistance
Clinical trial NCT03322215 · TERMINATED
Trial details
- NCT number
- NCT03322215
- Sponsor
- Theodoros Foukakis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-24
- Primary completion
- 2021-04-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.